[1] Ashley EA. The precision medicine initiative: a new national effort. JAMA, 2015,313:2119-2120.
[2] Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med, 2015,372:793-795.
[3] Zhang X, Liang Z, Wang S, et al. Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology. Cancer Biol Med, 2019,16:189-204.
[4] Boycott KM, Vanstone MR, Bulman DE, et al. Rare-disease genetics in the era of next generation sequencing: discovery to translation. Nat Rev Genet, 2013,14:681-691.
[5] Sun L, Liang B, Zhu L, et al. The rise of the genetic counseling profession in China. Am J Med Genet C Semin Med Genet, 2019,181:170-176.
[6] Baty BJ. Genetic counseling: Growth of the profession and the professional. Am J Med Genet C Semin Med Genet, 2018,178:54-62.
[7] Shendure J, Balasubramanian S, Church GM, et al. DNA sequencing at 40: past, present and future. Nature, 2017,550:345-353.
[8] Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A, 1977,74:5463-5467.
[9] Green ED, Rubin EM, Olson MV. The future of DNA sequencing. Nature, 2017,550:179-181.
[10] Yibin G. Sequencing technology in gene diagnosis and its application]. Yi Chuan, 2014,36:1121-1130.
[11] van Dijk EL, Auger H, Jaszczyszyn Y, et al. Ten years of next-generation sequencing technology. Trends Genet, 2014,30:418-426.
[12] Xuan J, Yu Y, Qing T, et al. Next-generation sequencing in the clinic: promises and challenges. Cancer Lett, 2013,340:284-295.
[13] 中国食品药品检定研究院. 第二代测序技术检测试剂质量评价通用技术指导原则. 2016. http://www.nicpbp.org.cn/CL0149/8495.html.
[14] Ye F, Gao H, Xiao L, et al. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma. Int J Cancer, 2019,144:1321-1330.
[15] Chrystoja CC, Diamandis EP. Whole genome sequencing as a diagnostic test: challenges and opportunities. Clin Chem, 2014,60:724-733.
[16] Bean LJH, Funke B, Carlston CM, et al. Diagnostic gene sequencing panels: from design to report-a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 2020,22:453-461.
[17] Ballester LY, Luthra R, Kanagal-Shamanna R, et al. Advances in clinical next-generation sequencing: target enrichment and sequencing technologies. Expert Rev Mol Diagn, 2016,16:357-372.
[18] Vora NL, Gilmore K, Brandt A, et al. An approach to integrating exome sequencing for fetal structural anomalies into clinical practice. Genet Med, 2020.
[19] Sun Y, Li Y, Chen M, et al. Anovel silent mutation in the L1CAM gene causing fetal hydrocephalus detected by whole-exome sequencing. Front Genet, 2019,10:817.
[20] Bayley H. Single-molecule DNA sequencing: Getting to the bottom of the well. Nat Nanotechnol, 2017,12:1116-1117.
[21] Jenjaroenpun P, Wongsurawat T, Pereira R, et al. Complete genomic and transcriptional landscape analysis using third-generation sequencing: a case study of Saccharomyces cerevisiae CEN.PK113-7D. Nucl Acids Res, 2018,46:e38.
[22] Chen D, Zhao Q, Jiang L, et al. TGStools: Abioinformatics suit to facilitate transcriptome analysis of long reads from third generation sequencing platform. Genes (Basel), 2019,.
[23] Eid J, Fehr A, Gray J, et al. Real-time DNA sequencing from single polymerase molecules. Science, 2009,323:133-138.
[24] Moss EL, Maghini DG, Bhatt AS. Complete, closed bacterial genomes from microbiomes using nanopore sequencing. Nat Biotechnol, 2020.
[25] Gilpatrick T, Lee I, Graham JE, et al. Targeted nanopore sequencing with Cas9-guided adapter ligation. Nat Biotechnol, 2020.
[26] Reeve JL, Frayling IM, Twomey PJ. Challenges in molecular diagnosis of Wilson disease. J Clin Pathol, 2020.
[27] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015,17:405-424.
[28] Czlonkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers, 2018,4:21.
[29] Stattermayer AF, Entenmann A, Gschwantler M, et al. The dilemma to diagnose Wilson disease by genetic testing alone. Eur J Clin Invest, 2019,49:e13147.
[30] Sullivan PF, Agrawal A, Bulik CM, et al. Psychiatricgenomics: An update and an agenda. Am J Psychiat, 2018,175:15-27. |
